Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -4.92% vs 12.95% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -112.77% vs 29.51% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -36.46% vs 26.52% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -3.70% vs -6.90% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of BioMarin Pharmaceutical, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -4.92% vs 12.95% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 5.98% vs 26.69% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -112.77% vs 29.51% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -128.93% vs 162.62% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -36.46% vs 26.52% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 17.50% vs 256.91% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -3.70% vs -6.90% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -13.33% vs -21.05% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






